Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Riverview Financial Corp (RIVE)
|
Add to portfolio |
|
|
Price: |
$10.20
| | Metrics |
OS: |
9.36
|
M
| |
12
|
% ROE
|
Market cap: |
$95.5
|
M
| |
|
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
$1.34
| |
7.6
|
x P/E
|
BVPS
|
$11.49
| |
0.89
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
Revenues | 41.8 | 47.1 | 52.2 | 27.2 | 21.4 | 15.9 | 17.9 | 12.5 |
Revenue growth | -11.3% | -9.8% | 92.1% | 27.1% | 34.3% | -11.1% | 43.4% | 13.0% |
Cost of goods sold | 25.3 | 28.2 | 26.2 | 18.5 | 11.4 | 12.1 | 9.2 | 7.5 |
Gross profit | 16.4 | 18.9 | 25.9 | 8.7 | 9.9 | 3.8 | 8.7 | 5.0 |
Gross margin | 39.3% | 40.1% | 49.7% | 32.0% | 46.5% | 24.2% | 48.6% | 39.9% |
Selling, general and administrative | 25.6 | 0.8 | 0.9 | 0.5 | 0.3 | | | |
Research and development | | | | | | 1.2 | 1.2 | 0.8 |
General and administrative | | | | | | 0.3 | 0.4 | 0.3 |
EBITA | 16.4 | 18.9 | 25.9 | 8.7 | 9.9 | 1.1 | 6.2 | 2.9 |
EBITA margin | 39.3% | 40.1% | 49.7% | 32.0% | 46.5% | 7.2% | 34.4% | 23.4% |
Amortization of intangibles | 0.8 | 0.8 | 0.9 | 0.5 | 0.3 | 0.3 | 0.3 | 0.1 |
EBIT | 15.6 | 18.1 | 25.1 | 8.1 | 9.6 | 0.9 | 5.9 | 2.8 |
EBIT margin | 37.3% | 38.4% | 48.1% | 30.0% | 44.9% | 5.6% | 32.8% | 22.3% |
Pre-tax income | -21.0 | 5.0 | 13.2 | -1.4 | 4.0 | -0.8 | 2.7 | 1.1 |
Income taxes | 0.3 | 0.7 | 2.4 | 3.5 | 1.0 | 0.0 | 0.7 | -0.3 |
Tax rate | | 14.1% | 17.9% | | 23.9% | 3.6% | 26.7% | |
Net income | -21.2 | 4.3 | 10.9 | -4.9 | 3.1 | -0.8 | 2.7 | 1.5 |
Net margin | -50.8% | 9.1% | 20.8% | -18.1% | 14.4% | -4.7% | 15.2% | 11.7% |
|
Diluted EPS | ($2.29) | $0.47 | $1.19 | ($0.93) | $0.95 | ($0.28) | $1.00 | $0.78 |
Shares outstanding (diluted) | 9.3 | 9.2 | 9.1 | 5.3 | 3.2 | 2.7 | 2.7 | 1.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|